Prasugrel switching from clopidogrel after percutaneous coronary intervention for acute coronary syndrome in Taiwanese patients: an analysis of safety and efficacy
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1868-4297
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Prasugrel switching from clopidogrel after percutaneous coronary intervention for acute coronary syndrome in Taiwanese patients: an analysis of safety and efficacy ; day:4 ; month:4 ; year:2021 ; pages:1-10
Cardiovascular intervention and therapeutics ; (4.4.2021), 1-10
- Creator
-
Liu, Ping-Yen
Su, Cheng-Huang
Kuo, Feng-Yu
Lee, Wen-Lieng
Wang, Yi-Chih
Lin, Wei-Shiang
Chu, Pao-Hsien
Lu, Tse-Min
Lo, Ping-Han
Lee, Cheng-Han
Lan, Wei-Ren
Huang, Chien-Lung
Tsukiyama, Shuji
Yang, Wei-Chen
Cheng, Li-Chung
Rafael, Virginia
Nikolajsen, Christian
Yin, Wei-Hsian
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s12928-021-00771-w
- URN
-
urn:nbn:de:101:1-2021102819255184656527
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:33 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Liu, Ping-Yen
- Su, Cheng-Huang
- Kuo, Feng-Yu
- Lee, Wen-Lieng
- Wang, Yi-Chih
- Lin, Wei-Shiang
- Chu, Pao-Hsien
- Lu, Tse-Min
- Lo, Ping-Han
- Lee, Cheng-Han
- Lan, Wei-Ren
- Huang, Chien-Lung
- Tsukiyama, Shuji
- Yang, Wei-Chen
- Cheng, Li-Chung
- Rafael, Virginia
- Nikolajsen, Christian
- Yin, Wei-Hsian
- SpringerLink (Online service)
Other Objects (12)
Percutaneous coronary intervention of specific coronary lesions
CYP2C19 Polymorphism in Ischemic Heart Disease Patients Taking Clopidogrel After Percutaneous Coronary Intervention in Egypt
Platelet glycoprotein IIb/IIIa inhibitor tirofiban in clopidogrel-naïve patients undergoing elective percutaneous coronary intervention
Complications of Percutaneous Coronary Interventions
Percutaneous Coronary Interventions in Women
Dynamic coronary roadmapping during percutaneous coronary intervention: a feasibility study
Proton Pump Inhibitor and Clopidogrel Use After Percutaneous Coronary Intervention and Risk of Major Cardiovascular Events
Device entrapment during percutaneous coronary intervention
Coronary Perforation Complicating Percutaneous Coronary Intervention – A Case Illustration and Review
The clopidogrel after surgery for coronary artery disease (CASCADE) randomized controlled trial: clopidogrel and aspirin versus aspirin alone after coronary bypass surgery [NCT00228423]
Percutaneous Coronary Intervention versus Coronary Artery Bypass Graft in Acute Coronary Syndrome patients with Renal Dysfunction
The impact of cytochrome 450 and Paraoxonase polymorphisms on clopidogrel resistance and major adverse cardiac events in coronary heart disease patients after percutaneous coronary intervention
Percutaneous coronary intervention of specific coronary lesions
CYP2C19 Polymorphism in Ischemic Heart Disease Patients Taking Clopidogrel After Percutaneous Coronary Intervention in Egypt
Platelet glycoprotein IIb/IIIa inhibitor tirofiban in clopidogrel-naïve patients undergoing elective percutaneous coronary intervention
Complications of Percutaneous Coronary Interventions
Percutaneous Coronary Interventions in Women
Dynamic coronary roadmapping during percutaneous coronary intervention: a feasibility study
Proton Pump Inhibitor and Clopidogrel Use After Percutaneous Coronary Intervention and Risk of Major Cardiovascular Events
Device entrapment during percutaneous coronary intervention
Coronary Perforation Complicating Percutaneous Coronary Intervention – A Case Illustration and Review
The clopidogrel after surgery for coronary artery disease (CASCADE) randomized controlled trial: clopidogrel and aspirin versus aspirin alone after coronary bypass surgery [NCT00228423]
Percutaneous Coronary Intervention versus Coronary Artery Bypass Graft in Acute Coronary Syndrome patients with Renal Dysfunction
The impact of cytochrome 450 and Paraoxonase polymorphisms on clopidogrel resistance and major adverse cardiac events in coronary heart disease patients after percutaneous coronary intervention
Percutaneous coronary intervention of specific coronary lesions
CYP2C19 Polymorphism in Ischemic Heart Disease Patients Taking Clopidogrel After Percutaneous Coronary Intervention in Egypt
Platelet glycoprotein IIb/IIIa inhibitor tirofiban in clopidogrel-naïve patients undergoing elective percutaneous coronary intervention
Complications of Percutaneous Coronary Interventions
Percutaneous Coronary Interventions in Women
Dynamic coronary roadmapping during percutaneous coronary intervention: a feasibility study
Proton Pump Inhibitor and Clopidogrel Use After Percutaneous Coronary Intervention and Risk of Major Cardiovascular Events
Device entrapment during percutaneous coronary intervention
Coronary Perforation Complicating Percutaneous Coronary Intervention – A Case Illustration and Review
The clopidogrel after surgery for coronary artery disease (CASCADE) randomized controlled trial: clopidogrel and aspirin versus aspirin alone after coronary bypass surgery [NCT00228423]
Percutaneous Coronary Intervention versus Coronary Artery Bypass Graft in Acute Coronary Syndrome patients with Renal Dysfunction